Elevator Pitch I like Hong Kong-listed automobile dealer China Yongda Automobiles Services Holdings Limited (OTC:CYYHF) [3669:HK] as a proxy for BMW (OTCPK:BMWYY) sales in China and its growing ancillary businesses. The company’s recent acquisition also helps it increase exposure to key luxury brands and lower-tier cities. China Yongda trades atRead More →

Health-care providers and organizations bear the responsibility for rooting out bias in medical care, experts say. In the meantime, though, there are steps patients can take to shield themselves. Research shows that patients of different genders, colors, sexual orientations and sizes don’t always receive the same quality of care duringRead More →

Chinese Internet giant Tencent (OTCPK:TCEHY) has numerous strengths which should appeal to investors. It is a complex company which I detailed in an article last year. Business services, advertising, and fintech will provide strategic long-term growth based on its massive WeChat platform. Its core gaming platform looks set to re-assertRead More →

CK Hutchison Holdings Ltd. (OTCPK:CKHUF, OTCPK:CKHUY) is an industrial conglomerate headquartered in Hong Kong. However, the European market has surpassed the Asian special administrative zone as the group’s most important geography. I therefore believe that investors should look at the company differently than its more home market-focussed peers. Please note:Read More →

Ongoing tensions between the U.S. and China and unreliable back-and-forth in communication paired with the exit of a large shareholder have triggered a correction in Alibaba’s (BABA) stock price. Source: Alibaba Investor Relations Despite stellar earnings and financials, investors take a much more negative view currently as sentiment is vastlyRead More →

Worldwide investors commit millions of dollars to drug companies, hoping that a new drug will become a blockbuster. However, before committing, investors should consider a thorough scientific due diligence to reduce risk. On May 7th, Actinogen, a small-cap Australian company, announced that their phase-2 trial of Xanamem showed no cognitiveRead More →